MODERN PRINCIPLES OF TREATING ULCERATIVE COLITIS: FROM SIMPLE TO COMPLEX

Abstract

Currently, the choice of medications for the treatment of non-specific ulcerative colitis and the determination of its duration remain a controversial issue. When treating ulcerative colitis, 5-aminosalicylic acid derivatives (mesalazine) are used as a first-line therapy. The choice of a drug and its form requires an individual approach, and when making a decision about therapy, it is necessary to take into account the duration of the inflammatory process, the activity of the inflammatory process, and the level of drug safety.